News | November 14, 2025
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
Poviztra is a second brand of Wegovy
The device delivers clear, high-quality images to support accurate diagnoses across a broad range of patient groups
Oral semaglutide 25 mg was associated with the same weight loss efficacy in women with obesity regardless of menopausal stage, and patients reported improvements in physical function, respectively
The expanded approval allows Kerendia to be prescribed to heart failure patients with a LVEF of 40% or more
The FDA’s review also revealed delays in Philips’ internal investigations, with 54 inquiries failing to meet targeted completion dates—23 of which were delayed by more than 100 days
Vitiligo, affecting over 90 per cent of patients in its non-segmental form, is characterized by symmetrical white patches on both sides of the body
AI-powered cardiometabolic wellness platform for India’s workforce
Subscribe To Our Newsletter & Stay Updated
